Netrin-1 prevents the development of cardiac hypertrophy and heart failure

Molecular Medicine Reports
Nan WangYan Zhu

Abstract

The aim of the present study was to examine whether netrin-1 is involved in the development of cardiac hypertrophy, induced by pressure overload. For this investigation, thoracic transverse aortic constriction (TAC) was performed in mice. A total of 18 mice were divided into three groups (n=6 per group): Sham, TAC and TAC + recombinant netrin-1. Neonatal rat cardiomyocytes were stimulated with endothelin-1 (ET-1), and samples were collected to examine the expression levels of netrin‑1 by western blot analysis and the mRNA expression of A‑type natriuretic peptide by reverse transcription‑quantitative polymerase chain reaction. It was found that the expression of netrin‑1 was decreased in the TAC mice and in the neonatal rat cardiomyocytes in response to ET‑1 stimulation. Netrin‑1 eliminated ventricular remodeling, cardiac dysfunction and DNA damage during pressure overload. Furthermore, analysis of the signaling events indicated that netrin‑1‑mediated protection against cardiac hypertrophy was attributed to interruption of the activation of mitogen‑activated protein kinase kinase (MEK) kinase‑1 (K1)‑dependent MEK‑extracellular signal‑regulated protein kinase 1/2 (ERK1/2) and c‑Jun N‑terminal kinase 1/2 (JNK1/2). Therefore, netri...Continue Reading

References

Nov 15, 1996·Science·M Tessier-Lavigne, C S Goodman
Apr 21, 1999·Current Opinion in Cell Biology·T P Garrington, G L Johnson
Jul 5, 2003·Molecular and Cellular Biochemistry·Tána RavingerováMonika Strnisková
Jun 24, 2004·Journal of Biochemistry·Keisuke Kuida, Diane M Boucher
Jul 22, 2004·JAMA : the Journal of the American Medical Association·Véronique L RogerSteven J Jacobsen
Jun 1, 2005·Lancet·John J V McMurray, Marc A Pfeffer
Jun 18, 2005·Brain Research. Brain Research Reviews·María J BarallobreEduardo Soriano
Oct 6, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ngoc P LyT Bernard Kinane
Jan 6, 2009·Nature Immunology·Peter RosenbergerHolger K Eltzschig
Aug 25, 2009·The American Journal of Pathology·Weiwei WangGanesan Ramesh
Jan 16, 2010·American Journal of Respiratory and Critical Care Medicine·Valbona MirakajPeter Rosenberger
Aug 10, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Raghu Kempegowda TadagavadiGanesan Ramesh
Nov 26, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Valbona MirakajPeter Rosenberger
Jan 26, 2011·European Journal of Clinical Investigation·Satoshi SuzukiIsao Kubota
Jun 1, 2011·PloS One·Almut GrenzHolger K Eltzschig
Feb 4, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lee SiggensRoger Foo
Jan 3, 2013·The Journal of Clinical Investigation·Jop H van BerloJeffery D Molkentin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Cardiovascular Homeostasis

Cardiovascular regulation and homeostasis is important in maintaining health and dysfunction may lead to cardiovascular diseases. Nitric oxide and vascular endothelium are one of many molecules involved in the homeostatic mechanism. Here is the latest research on cardiovascular homeostasis.